CSL Limited (ASX:CSL)
Pharmaceuticals, Biotechnology & Life Sciences
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL Limited (ASX:CSL) share price
CSL Limited (ASX:CSL) share price news
ASX Growth Shares
Avita Therapeutics (ASX:AVH) sinks 10% on BARDA update
The Avita Therapeutics Inc (ASX: AVH) share price was trading 10.53% lower today following an investor update to do with its BARDA partnership.
July 13, 2020
Experts
June 2020 – ASX 200 market recap
What a month it was for the S&P/ASX 200 (INDEXASX: XJO) and markets more broadly in June 2020, rallying again to cap off the strongest quarter for the ASX in over 20 years.
July 8, 2020
Editor's picks
S&P/ASX 200 (XJO) today – 6 stocks you need to watch
The S&P/ASX 200 (INDEXASX: XJO) is expected to open lower on Monday. Telstra (ASX:TLS) shares, AdBri Ltd (ASX:ABC) and CSL Limited (ASX:CSL) will be the ASX shares to watch.
July 6, 2020
ASX Share Ideas
S&P/ASX 200 index to pop Tuesday morning – stocks to watch
The S&P/ASX 200 (INDEXASX: XJO) is expected to jump this morning, according to data from the Sydney Futures Exchange. Here’s everything you need to know.
June 30, 2020
Today's ASX news
CSL (ASX:CSL) reveals US$450 million acquisition
CSL (ASX:CSL) has announced a US$450 million acquisition to the market, AMT-061.
June 25, 2020
Today's ASX news
CSL’s (ASX:CSL) CFO just left to join BHP (ASX:BHP)
The chief financial officer (CFO) of CSL (ASX:CSL) has left to join BHP (ASX:BHP).
June 17, 2020
Today's ASX news
CSL (ASX:CSL) announces an acquisition
CSL (ASX:CSL) has announced an acquisition to the market this morning. It’s called Vitaeris, a clinical-stage biotechnology company.
June 9, 2020
Editor's picks
S&P/ASX 200 (XJO) tipped to fall, FBR & CSL shares rally
The S&P/ASX 200 (INDEXASX: XJO) is tipped to open slightly lower on Friday with the most popular Sydney Futures Exchange contract pointing to a 14-point decline from yesterday. Here’s what you need to know.
June 5, 2020
Today's ASX news
CSL (ASX:CSL) share price up on new debt. Is it a buy?
Is the CSL (ASX:CSL) share price a buy after the healthcare giant announced new debt to strengthen its debt maturity profile.
May 7, 2020